Journal of Clinical Investigation · 2003 · 125 citations · 37 references
Life SciencesCell BiologyEndocrinologyApoptosisMetabolic PhysiologyMitochondrial BiologyDiabetes MellitusMitochondrial DysfunctionMitochondrial PhysiologyMitochondrial SignalingPancreatic EndocrinologyPancreatic HormonesBeta Cell ApoptosisBeta Cell BiologyBeta-cell DysfunctionImpaired Glucose ToleranceIslet Cell DysfunctionIslet Cell MassKnockout AnimalsPancreatic Islet Cells
Diabetes is caused by an absolute (type 1) or relative (type 2) deficiency of insulin-producing beta cells. We have disrupted expression of the mitochondrial protein frataxin selectively in pancreatic beta cells. Mice were born healthy but subsequently developed impaired glucose tolerance progressing to overt diabetes mellitus. These observations were explained by impairment of insulin secretion due to a loss of beta cell mass in knockout animals. This phenotype was preceded by elevated levels of reactive oxygen species in knockout islets, an increased frequency of apoptosis, and a decreased number of proliferating beta cells. Hence, disruption of the frataxin gene in pancreatic beta cells causes diabetes following cellular growth arrest and apoptosis, paralleled by an increase in reactive oxygen species in islets. These observations might provide insight into the deterioration of beta cell function observed in different subtypes of diabetes in humans.
37
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Takeshi Nishikawa, Diane Edelstein, Xue Du et al. · Nature · 2000 · 4.3K citations
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir et al. · Diabetes · 2003 · 4K citations
Medicine, Endocrinology, Physiology +17